multiple

Documents about multiple

• Multiple patterns, multiple explanations#113311PhilArchive
• Melphalan, Peripheral Stem Cell Transplantation, and Interleukin-2 Followed by Interferon Alfa in Treating Patients With Advanced Multiple Myeloma#127581ClinicalTrials.gov
• Viral Immunotherapy in Relapsed/Refractory Multiple Myeloma#28301ClinicalTrials.gov
• Étude des mécanismes de résistance des cellules du Myélome Multiple aux Immunothérapies#194363HAL (France)
• Short-term B-cell Depletion in Relapsing Multiple Sclerosis#230342ClinicalTrials.gov
• Applications of Nanotechnology in Multiple Sclerosis by Respiratory Samples#230428ClinicalTrials.gov
• Donor Immune Cells (TGFbi NK Cells) and Isatuximab for the Treatment of Relapsed or Refractory Multiple Myeloma#201786ClinicalTrials.gov
• Once weekly versus twice weekly carfilzomib dosing in patients with relapsed and refractory multiple myeloma (A.R.R.O.W.): interim analysis results of a randomised, phase 3 study#296806Gestión del Repositorio Documental de la Universidad de Salamanca
• Time Restricted Eating Outcomes in Multiple Sclerosis#143738ClinicalTrials.gov
• Multiple Myeloma Trial of Orally Administered Salmonella Based Survivin Vaccine#283113ClinicalTrials.gov
• Cell therapy in multiple sclerosis: An overview#147484HAL (France)
• Early Access Treatment With Daratumumab for (Relapsed or Refractory) Multiple Myeloma#174880ClinicalTrials.gov
• Genomic and Phenotypic Determinants of Resistance to Immunotherapies in Multiple Myeloma#184866ClinicalTrials.gov
• Eficacia del ejercicio físico aeróbico sobre la fatiga en personas con esclerosis múltiple#273712Gestión del Repositorio Documental de la Universidad de Salamanca
• Sequential vs alternating administration of VMP and Rd in elderly patients with newly diagnosed MM#296804Gestión del Repositorio Documental de la Universidad de Salamanca
• Vactosertib in Combination w/ Pomalidomide in Relapsed or Relapsed and Refractory Multiple Myeloma#18579ClinicalTrials.gov
• Predicting Reading Comprehension: Investigating the Influence of Multiple Variables Through Multiple Regression Analysis#72205PhilArchive
• Autologous Dendritic Cell Therapy in Patients With Relapsed or Refractory Multiple Myeloma#201790ClinicalTrials.gov
• Refining the role of selinexor in multiple myeloma: strategic use in a shifting treatment landscape#202763IRIS
• Clinical Activity of Metformin With High-dose of Dexamethasone in Relapse Multiple Myeloma#18540ClinicalTrials.gov
• Carfilzomib In Combination With Bendamustine And Dexamethasone In Refractory Or Relapsed Multiple Myeloma#148750ClinicalTrials.gov
• An innovative Bayesian multiple indicator-multiple cause analysis of bank productivity#168005Birkbeck Institutional Research Online
• An innovative Bayesian multiple indicator-multiple cause analysis of bank productivity#168552Birkbeck Institutional Research Online
• A Study to Evaluate RO7851624 in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)#181753ClinicalTrials.gov
• Digital patient experience tools in multiple sclerosis: a landscape analysis of the global Patient-Reported Outcomes in Multiple Sclerosis (PROMS) initiative#5569Europe PMC
• Once-weekly Versus Twice-weekly Carfilzomib in Combination With Dexamethasone in Adults With Relapsed and Refractory Multiple Myeloma#140989ClinicalTrials.gov
• A Study of BCMA/CD19 Dual-Target CAR-T Cell Immunotherapy for Relapsed or Refractory Multiple Myeloma#226278ClinicalTrials.gov
• Overview of Differences and Similarities of Published Mixed Treatment Comparisons on Pharmaceutical Interventions for Multiple Sclerosis#254358IRIS
• Multiple Selves. The Story#86044PhilArchive
• Multiple policy interest rates and economic performance in a multiple monetary-policy-tool environment#11087Crossref
• CAR-T Cells in Treating Patients With Relapsed or Refractory Multiple Myeloma#253055ClinicalTrials.gov
• Les portraits de Lita Cabellut : esthétique du double et/ou du multiple#294592HAL (France)
• Quality of Life and Treatment Outcomes in RRMM Patients Receiving Advanced vs. Conventional Immunotherapies#18599ClinicalTrials.gov
• A "negative"dendritic Cell-based Vaccine for the Treatment of Multiple Sclerosis: a First-in-human Clinical Trial#123567ClinicalTrials.gov
• Susceptibility-guided Bismuth Quadruple Therapy for Multiple-resistant Helicobacter Pylori Strains#226294ClinicalTrials.gov
• Functional connectivity dynamics of monoaminergic circuits related to fatigue in multiple sclerosis#257188Europe PMC
• Prognostic and biological implications of genetic abnormalities in multiple myeloma undergoing autologous stem cell transplantation: t(4;14) is the most relevant adverse prognostic factor, whereas RB deletion as a unique abnormality is not associated with adverse prognosis#294461Gestión del Repositorio Documental de la Universidad de Salamanca
• Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma#127820ClinicalTrials.gov
• Traitement du Myélome Multiple par l’inhibition des facteurs Polycomb#156094HAL (France)
• Study of Alternative and Approved Dosing Regimens of Belantamab Mafodotin, Bortezomib, and Dexamethasone (BVd) in Participants With Relapsed/Refractory Multiple Myeloma#267997ClinicalTrials.gov
• Jalview Version 2—a multiple sequence alignment editor and analysis workbench#6502OpenAlex
• MRD-Adaptive Guided Immunotherapy With CAR-T for Transplant-Ineligible Patients With Multiple Myeloma#28326ClinicalTrials.gov
• A Real-world Study to Assess the Use of Siponimod in Spain to Treat Patients With Secondary Progressive Multiple Sclerosis#141136ClinicalTrials.gov
• Check or Not to Check: Adolescents’ Sourcing Practices When Writing from Multiple Texts#160499OSF
• Study of MAGE-A3 and NY-ESO-1 Immunotherapy in Combo With DTPACE Chemo and Auto Transplantation in Multiple Myeloma#201774ClinicalTrials.gov
• The Relationship Between Musical Aptitude and Multiple Intelligences in High School Music Students#289590Scholars Crossing
• Aristotle on multiple demonstration#84869PhilArchive
• Against Utopianism: Noncompliance and Multiple Agents#92115PhilArchive
• Multiple Generality in Scholastic Logic#112957PhilArchive
• Multiple realization and methodology#115604PhilArchive

Related topics